TipRanks
NeonMind Biosciences Inc (DE:6UF0)
FRANKFURT:6UF0
Germany Market

NeonMind Biosciences Inc (6UF0) Income Statement

1 Followers

NeonMind Biosciences Inc Income Statement

Last quarter (Q1 2026), NeonMind Biosciences Inc's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q1, NeonMind Biosciences Inc's net income was C$-359.09K. See NeonMind Biosciences Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 25Jun 24Mar 24Feb 23Feb 22
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Operating Expenses
C$ 1.33MC$ 1.06M-C$ 1.75MC$ 7.78M
Depreciation and Amortization
C$ 0.00C$ 404.70KC$ 1.70MC$ 1.13KC$ 689.00
EBITDA
C$ -1.58MC$ 403.40K-C$ -1.75MC$ -7.83M
Operating Income
C$ -1.33MC$ -1.06M-C$ -1.75MC$ -7.83M
Other Income/Expenses
C$ -428.11KC$ -484.80K-C$ -3.47KC$ 1.13M
Pretax Income
C$ -1.76MC$ -1.55M-C$ -2.03MC$ -6.68M
Net Income
C$ -1.75MC$ -1.54M-C$ -2.03MC$ -7.21M
Per Share Metrics
Basic EPS
C$ -0.03C$ -0.03C$ -0.08C$ -1.80C$ -7.33
Diluted EPS
C$ -0.03C$ -0.03C$ -0.08C$ -1.80C$ -7.33
Weighted Average Shares Outstanding
99.52M 55.69K 45.07M 1.13M 983.30K
Weighted Average Shares Outstanding (Diluted)
99.52M 55.69K 45.07M 1.13M 983.30K
Currency in CAD

NeonMind Biosciences Inc Earnings and Revenue History